Accelevir Diagnostics

Accelevir Diagnostics is a growing Maryland biotechnology company creating innovative assays for ultra-rare analytes in infectious disease and beyond. With expertise spanning virology, immunology, genomics and cell and gene therapy, our team develops, scales, and commercializes complex assay workflows to support our biopharma partners from basic research through clinical trials. We are currently focused on advancing new assays for persistent HIV-1 and other clinically important viral infections. To date, we have received over $15M in federal, state and private funding to advance our assays. We are actively working with leading academic and bio-pharma groups to provide our assays in support of translational research and early-stage clinical trials aimed at developing game-changing therapeutics with the potential to cure chronic viral infections.